A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

Title
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Authors
Keywords
AS1411, Nucleolin, Renal cell carcinoma, Aptamer
Journal
INVESTIGATIONAL NEW DRUGS
Volume 32, Issue 1, Pages 178-187
Publisher
Springer Nature
Online
2013-11-15
DOI
10.1007/s10637-013-0045-6

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search